Wolters Kluwer Health's New Forecasting Service Models Pharma's Future

inThought offers market data, analysis and forecasting from a single source

BRIDGEWATER, N.J., June 29 /PRNewswire/ -- Wolters Kluwer Health, a leading
provider of information and business intelligence for students, professionals
and institutions in medicine, nursing, allied health, pharmacy and the
pharmaceutical industry, today introduced Wolters Kluwer Health inThought(TM),
a new market research service that offers an array of pharmaceutical
forecasting capabilities. inThought was developed to help financial analysts,
health care suppliers and drug makers understand where developmental drugs,
medical devices, and therapies are positioned today and where they are likely
headed in the future.

inThought is among the first of a new generation of research services that can
deliver data, analysis and forecasting from a single source, an approach that
is both cost effective and helps streamline the market research process.
inThought integrates Wolters Kluwer Health's trusted clinical, prescription,
managed markets, and patient information -- recognized to be of the highest
quality in the industry -- together with the keen insight and forecasting
abilities developed by a team of highly skilled individuals including
researchers, analysts and physicians.

"With research headcounts down, there's a fundamental shift in the way
analysts and pharma customers want their research delivered," said Ben
Weintraub, Director of Research, Wolters Kluwer Health inThought. "Rather
than simply striving to offer more data faster, our approach sifts through the
clutter to synthesize what is truly important."

Customers now have all of the tools they need from a single, independent
source to aid them in making more efficient decisions about their products,
markets and competitors. inThought's progressive approach benefits from the
wealth of knowledge and experience provided by Wolters Kluwer Health Pharma
Solutions' professional data analysts, a distinction that helps identify
trends as they unfold.

"With inThought, we alleviate one of the main issues with traditional pharma
research products: once you buy it, you still have to make time to use it and
understand the implications for your product," said Mark Spiers, President and
CEO, Wolters Kluwer Health, Pharma Solutions. "This approach provides an edge
for understanding the future market for a pharmaceutical brand or medical
device."

inThought research and analysis is available to customers through products
such as research alerts geared toward specific customer requirements;
subscriptions to a powerful, Web-based drug pipeline database that integrates
inThought forecasts with detailed monitoring of drug development programs
around the world; regular conference calls to connect customers with medical
experts providing the physician perspective; revenue forecasts and probability
of approval models for 300+ drugs in development; syndicated research reports
that delve deep into specific markets; and custom research projects and
counsel designed to meet individual customer needs.

For more information about Wolters Kluwer Health inThought, visit
www.in-thought.com.

About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information
and business intelligence for students, professionals and institutions in
medicine, nursing, allied health, pharmacy and the pharmaceutical industry.
Major brands include traditional publishers of medical and drug reference
tools and textbooks, such as Lippincott Williams & Wilkins and Facts &
Comparisons(R); electronic information providers, such as Ovid, UpToDate(R),
Medi-Span(R) and ProVation(R) Medical; and pharmaceutical information
providers such as Adis International and Source(R).

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global
information services and publishing company. The company provides products and
services for professionals in the health, tax, accounting, corporate,
financial services, legal, and regulatory sectors. Wolters Kluwer had 2008
annual revenues of euro 3.4 billion ($4.9 billion), employs approximately
20,000 people worldwide, and maintains operations in over 35 countries across
Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is
headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext
Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit
www.wolterskluwer.com for information about our market positions, customers,
brands, and organization.

Contact: Tom Kivett
Kivett & Company Communications
(212) 727-2935
tkivett@kivettandco.com

SOURCE Wolters Kluwer Health

Tom Kivett, Kivett & Company Communications, +1-212-727-2935,
tkivett@kivettandco.com, for Wolters Kluwer Health